Meeting Podcasts

25-26 October 2021, Trieste, ItalyProvide an update on the current pandemic in multiple key regions of the world. The event intends to highlight ICGEB activities related to COVID-19 and to get a feedback from our Member States on how to cooperate at best against future challenges.

5 October 2021, Trieste, ItalyLatest developments of this field, especially with regards to its connection with human disease and the development of novel therapeutic approaches.

28-30 September 2021, Trieste, ItalyFlow Cytometry has established as a critical technology for academic research and in clinical applications. The technique requires understanding of the basic principles and expertise to set up, perform and analyze results. 

19-22 November 2019, Trieste, ItalyICGEB-JRC Workshop on Genome Editing applications and beyond.

25-28 March 2019, Trieste, ItalyMouse models of disease are central to biomedical research in many different fields.

8-10 May 2019, Trieste, ItalyFlow Cytometry has established as a critical technology for academic research and for the clinicscience applications

21-22 February 2019, Trieste, ItalyThe Course fosters the collaboration with researchers and clinicians using UltraSound imaging for cardiovascular studies

22-24 October 2018, Trieste, ItalyThe course aims at providing an opportunity for young scientists, especially from least developed countries in endemic areas, for advanced training on the related topics

2-4 October 2018, Trieste, Italy[email protected] aims at instructing researchers in the use of fluorescence microscopy in life science applications

17-20 April 2018, Trieste, ItalyDrosophila melanogaster models for neurodegenerative diseases

19-22 March 2018, Trieste, ItalyThe course focuses on RNA structure, structure prediction, Editing, Ribozymes, Transport, RNA-protein recognition, Translation, Processing, splicing, microRNAs, Evolution of RNA sequences.

21-23 November 2017, Trieste, ItalyDementia represents the most common neurodegenerative disorder affecting approximately 5% of the elderly population over age 65 years.